Back
BrandywineGLOBAL - Global Income Opportunities Fund Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Sell
50
BWG
BrandywineGLOBAL - Global Income Opportunities Fund
Last Price:
$8.45
Seasonality Move:
-3.65%
Buy
80
TVTX
Travere Therapeutics, Inc.
Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
50
BrandywineGLOBAL - Global Income Opportunities Fund (BWG)
is a Sell
Is BrandywineGLOBAL - Global Income Opportunities Fund a Buy, Sell or Hold?
-
The current BrandywineGLOBAL - Global Income Opportunities Fund [BWG] share price is $8.48. The Score for BWG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BWG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BWG Stock Price Chart
What is BrandywineGLOBAL - Global Income Opportunities Fund's stock price today?
-
The BrandywineGLOBAL - Global Income Opportunities Fund share price today is $8.48The current trend is relatively stagnant and BWG is experiencing buying pressure, which is a positive indicator for future bullish movement.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $40.2800Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
BWG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 54.16 | Buy |
| Chaikin Money Flow: | 34753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.28 - 8.48) | Buy |
| Bollinger Bands (100): | (8.39 - 8.73) | Sell |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.67 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 1508490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.0318 - 36.4718) | Buy |
| Bollinger Bands (100): | (20.7309 - 34.2909) | Buy |
BWG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.45 | Buy |
| 20-day SMA: | 8.42 | Buy |
| 50-day SMA: | 8.45 | Buy |
| 200-day SMA: | 8.37 | Buy |
| 8-day EMA: | 8.46 | Buy |
| 20-day EMA: | 8.43 | Buy |
| 50-day EMA: | 8.45 | Buy |
| 200-day EMA: | 8.44 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.7 | Buy |
| 20-day SMA: | 35.23 | Buy |
| 50-day SMA: | 33.43 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 28.52 | Buy |
| 20-day EMA: | 16.32 | Buy |
| 50-day EMA: | 7.67 | Buy |
| 200-day EMA: | 2.09 | Buy |
BrandywineGLOBAL - Global Income Opportunities Fund Earnings Growth & BWG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
BrandywineGLOBAL - Global Income Opportunities Fund Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||